logo
Share SHARE
FONT-SIZE Plus   Neg

CA Technologies Appoints Michael Gregoire As CEO - Quick Facts

CA Technologies (CA) announced that it has appointed Michael Gregoire, 46, as its new chief executive officer, effective January 7, 2013. He will succeed William McCracken, 70, who has served as CA Technologies chief executive officer since January, 2010 and who is retiring effective March 31, 2013. McCracken also will leave the CA Technologies Board of Directors effective January 7, 2013.

Gregoire also was elected to the CA Technologies Board of Directors. Gregoire has 25-year of experience in the software and IT services industries. Most recently, Gregoire was chairman, president and chief executive officer of Taleo Corp.

Before joining Taleo, Gregoire spent four years at PeopleSoft, Inc. He was the executive vice president of PeopleSoft Global Services.

Gregoire also spent 12 years at EDS Corp., where he held a number of senior positions including executive director of the global Financial Markets Group, chief technologist for Manufacturing and Financial verticals, as well as several architecture and project management positions. Gregoire will relocate to the New York area.

The company stated that McCracken will continue to lead the company until Gregoire joins on January 7, 2013. He will assist Gregoire in the transition until his retirement on March 31, 2013.

The company also said it has entered into a consulting agreement with McCracken to further help with the transition through December 31, 2013.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT